Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Dudler

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Arthritis Research & Therapy|February 27, 2026
Sleep improvement in patients with rheumatoid arthritis treated with upadacitinib in real-world practice: results from the SLEERA studyThomas Hügle, Heino Prillwitz, Godehard Scholz, et al.
Rheumatology (Oxford, England)|May 17, 2022
Comparison of drug retention of TNF inhibitors, other biologics and JAK inhibitors in RA patients who discontinued JAK inhibitor therapyAndrea Amstad, Eleftherios Papagiannoulis, Almut Scherer, et al.
RMD Open|June 17, 2021
EULAR portfolio for Rheumatology training: a EULAR School of Rheumatology initiativeMarloes van Onna, Sofia Ramiro, Catherine Haines, et al.
Annals of the Rheumatic Diseases|February 7, 2012
Safety and efficacy of ocrelizumab in combination with methotrexate in MTX-naive subjects with rheumatoid arthritis: the phase III FILM trialWilliam Stohl, Juan Gomez-Reino, Ewa Olech, et al.
Dermatology (Basel, Switzerland)|January 10, 2015
The dermatologists' role in managing psoriatic arthritis: results of a Swiss Delphi exercise intended to improve collaboration with rheumatologistsWolf-Henning Boehncke, Mark David Anliker, Curdin Conrad, et al.
Rheumatology (Oxford, England)|September 2, 2017
Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritisDeshiré Alpizar-Rodriguez, Rüdiger B Mueller, Burkhard Möller, et al.
Scientific Reports|October 18, 2023
Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical careMyriam Riek, Almut Scherer, Burkhard Möller, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|March 2, 2018
The Global Spine Care Initiative: a systematic review for the assessment of spine-related complaints in populations with limited resources and in low- and middle-income communitiesMargareta Nordin, Kristi Randhawa, Paola Torres, et al.
Arthritis and Rheumatism|August 29, 2013
Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohortAdrian Ciurea, Almut Scherer, Pascale Exer, et al.
Clinical Rheumatology|January 23, 2017
The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritisD Alpizar-Rodriguez, Laure Brulhart, Ruediger B Mueller, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Arthritis Research & Therapy|February 27, 2026
Sleep improvement in patients with rheumatoid arthritis treated with upadacitinib in real-world practice: results from the SLEERA studyThomas Hügle, Heino Prillwitz, Godehard Scholz, et al.
Rheumatology (Oxford, England)|May 17, 2022
Comparison of drug retention of TNF inhibitors, other biologics and JAK inhibitors in RA patients who discontinued JAK inhibitor therapyAndrea Amstad, Eleftherios Papagiannoulis, Almut Scherer, et al.
RMD Open|June 17, 2021
EULAR portfolio for Rheumatology training: a EULAR School of Rheumatology initiativeMarloes van Onna, Sofia Ramiro, Catherine Haines, et al.
Annals of the Rheumatic Diseases|February 7, 2012
Safety and efficacy of ocrelizumab in combination with methotrexate in MTX-naive subjects with rheumatoid arthritis: the phase III FILM trialWilliam Stohl, Juan Gomez-Reino, Ewa Olech, et al.
Dermatology (Basel, Switzerland)|January 10, 2015
The dermatologists' role in managing psoriatic arthritis: results of a Swiss Delphi exercise intended to improve collaboration with rheumatologistsWolf-Henning Boehncke, Mark David Anliker, Curdin Conrad, et al.
Rheumatology (Oxford, England)|September 2, 2017
Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritisDeshiré Alpizar-Rodriguez, Rüdiger B Mueller, Burkhard Möller, et al.
Scientific Reports|October 18, 2023
Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical careMyriam Riek, Almut Scherer, Burkhard Möller, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|March 2, 2018
The Global Spine Care Initiative: a systematic review for the assessment of spine-related complaints in populations with limited resources and in low- and middle-income communitiesMargareta Nordin, Kristi Randhawa, Paola Torres, et al.
Arthritis and Rheumatism|August 29, 2013
Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohortAdrian Ciurea, Almut Scherer, Pascale Exer, et al.
Clinical Rheumatology|January 23, 2017
The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritisD Alpizar-Rodriguez, Laure Brulhart, Ruediger B Mueller, et al.
Pageof 8